Skip to main content
Premium Trial:

Request an Annual Quote

Eric Compton

Hologic has announced that its COO Eric Compton will leave at the end of December. Hologic appointed Compton as its COO in 2014. From 1995 to 2014, he worked at Johnson & Johnson in roles of increasing responsibility. For example, prior to joining Hologic, he served as the worldwide president of Ortho Clinical Diagnostics for Johnson & Johnson. 

The Scan

Review of Approval Process

Stat News reports the Department for Health and Human Services' Office of the Inspector General is to investigate FDA's approval of Biogen's Alzheimer's disease drug.

Not Quite Right

A new analysis has found hundreds of studies with incorrect nucleotide sequences reported in their methods, according to Nature News.

CRISPR and mRNA Together

Time magazine reports on the use of mRNA to deliver CRISPR machinery.

Nature Papers Present Smartphone Platform for DNA Diagnosis of Malaria, Mouse Lines for Epigenomic Editing

In Nature this week: a low-cost tool to detect infectious diseases like malaria, and more.